text: Igor V. Komarov was a coordinator of scientific projects financed by the Ministry of Education and Science of the Ukraine (three applied projects devoted to design of therapeutic peptides, including photocontrolled [http://science.univ.kiev.ua/research/theme/themefund/ ]), Alexander von Humboldt Foundation (Institute Partnershaft and Research Linkage Programs, in collaboration with Karlsruhe University (Karlsruhe, Germany)[http://www.ibg.kit.edu/nmr/english/26.php ] and Leibniz Institute of Molecular Pharmacology (Berlin, Germany)[http://www.leibniz-fmp.de/de/research/chemical-biology/res-groups-chembio/dathe-oehlke/projectspeptidelipidinteractio.html ]), private companies Degussa (the project was devoted to development of large-scale production of a ligand for Rhodium-based catalysts of asymmetric hydrogenation) and Enamine (six medicinal chemistry projects, lead discovery and lead optimization). He is currently a coordinator of a European Horizon2020 Research and Innovation Staff Exchange (RISE) Programme (2016–2019) Grant Agreement number: 690973 [http://pelico.org/ ], the title of the project – “Peptidomimetics with Photocontrolled Biological Activity”.